Novel prostate cancer target for diagnosis, imaging, detection of recurrence and response to therapy [ 2015 - 2018 ]

Research Grant

Researchers: Prof Colleen Nelson (Principal investigator) ,  Prof Bradley Walsh ,  Prof Pamela Russell

Brief description This project will generate the critical proof of concept to justify clinical development of a novel biomarker in prostate cancer which would bring significant benefit in terms of differential diagnosis of aggressive disease. The biomarker will be assessed for a functional role in prostate cancer and potential as a therapeutic target and use as a imaging agent in for monitoring disease progression and response to therapy. These investigations will be extended to other common solid tumours.

Funding Amount $AUD 731,497.43

Funding Scheme Development Grants

Notes Development Grant